•
Dec 31, 2019

IPG Photonics Q4 2019 Earnings Report

IPG Photonics' Q4 2019 revenue decreased 7% year-over-year, but exceeded guidance. Net loss per diluted share was $0.08, impacted by foreign exchange losses, higher inventory reserves, and impairment charges. The company generated $130 million in cash from operations.

Key Takeaways

IPG Photonics reported a 7% decrease in fourth-quarter revenue compared to the previous year, totaling $306.6 million. The company experienced a net loss per diluted share of $0.08, influenced by various charges. However, cash from operations remained strong at $130 million.

Fourth quarter revenue decreased 7% year over year to $307 million.

Materials processing sales accounted for 90% of total revenue, decreasing 11% year over year.

Sales decreased 21% in China, 17% in Europe, 37% in Japan and increased 30% in North America on a year over year basis.

Net loss per diluted share was $0.08, reduced by $0.99 due to foreign exchange losses, higher inventory reserves, and impairment charges.

Total Revenue
$307M
Previous year: $330M
-7.1%
EPS
$0.91
Previous year: $1.4
-35.0%
Gross Margin
40.5%
Previous year: 50.5%
-19.8%
Operating Margin
0.1%
Previous year: 29.1%
-99.7%
Cash from Operations
$130M
Gross Profit
$124M
Previous year: $167M
-25.5%
Cash and Equivalents
$680M
Previous year: $544M
+24.9%
Free Cash Flow
$104M
Previous year: $86.1M
+20.8%
Total Assets
$2.73B
Previous year: $2.57B
+6.1%

IPG Photonics

IPG Photonics

IPG Photonics Revenue by Segment

Forward Guidance

For the first quarter of 2020, IPG expects revenue of $220 million to $250 million and earnings per diluted share in the range of $0.00 to $0.30. This guidance assumes approximately $45 million in reduced revenue and $0.45 lower EPS from business disruption related to the novel coronavirus outbreak.

Positive Outlook

  • Significant long-term growth opportunities in welding
  • Significant long-term growth opportunities in fine processing of electric vehicle batteries
  • Significant long-term growth opportunities in our portfolio of new products addressing opportunities in microelectronics
  • Significant long-term growth opportunities in our portfolio of new products addressing opportunities in medical
  • Significant long-term growth opportunities in our portfolio of new products addressing opportunities in systems and beam delivery solutions

Challenges Ahead

  • Business disruption related to the novel coronavirus outbreak
  • Product demand
  • Order cancellations and delays
  • Competition
  • General economic conditions

Revenue & Expenses

Visualization of income flow from segment revenue to net income